Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,351) with videos related to
Page
of 136
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2019
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Axel Hauschild, Paolo A Ascierto, Dirk Schadendorf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
Georg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2013
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma
Steven J O'Day, Alexander M M Eggermont, Vanna Chiarion-Sileni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2013
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B Gerber, S Loibl, H Eidtmann, et al.
The Journal of Cell Biology
|
April 14, 2018
Lymphatic exosomes promote dendritic cell migration along guidance cues
Markus Brown, Louise A Johnson, Dario A Leone, et al.
Food & Nutrition Research
|
November 11, 2024
Environmental sustainability of food production and consumption in the Nordic and Baltic region - a scoping review for Nordic Nutrition Recommendations 2023
Helen Harwatt, Tim G Benton, Jan Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial
Peter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Oncotarget
|
April 9, 2019
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced <i>NRAS</i>- or <i>BRAF</i>-mutated melanoma
Carla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, et al.
Journal of the American Society for Mass Spectrometry
|
September 29, 2022
Next-Generation Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Source for Mass Spectrometry Imaging and High-Throughput Screening
Kevan T Knizner, Jacob P Guymon, Kenneth P Garrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Page
of 136
Search research articles
Search
Showing results (1071-1080 of 1,351) with videos related to
Sort By:
Page
of 136
European Journal of Cancer (Oxford, England : 1990)
|
December 22, 2019
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
Axel Hauschild, Paolo A Ascierto, Dirk Schadendorf, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 14, 2025
Clinical course of Merkel cell carcinoma: A DeCOG multicenter study of 1049 patients
Georg C Lodde, Ulrike Leiter, Anja Gesierich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2013
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma
Steven J O'Day, Alexander M M Eggermont, Vanna Chiarion-Sileni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2013
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B Gerber, S Loibl, H Eidtmann, et al.
The Journal of Cell Biology
|
April 14, 2018
Lymphatic exosomes promote dendritic cell migration along guidance cues
Markus Brown, Louise A Johnson, Dario A Leone, et al.
Food & Nutrition Research
|
November 11, 2024
Environmental sustainability of food production and consumption in the Nordic and Baltic region - a scoping review for Nordic Nutrition Recommendations 2023
Helen Harwatt, Tim G Benton, Jan Bengtsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2015
Intermittent High-Dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial
Peter Mohr, Axel Hauschild, Uwe Trefzer, et al.
Oncotarget
|
April 9, 2019
Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced <i>NRAS</i>- or <i>BRAF</i>-mutated melanoma
Carla M L van Herpen, Sanjiv S Agarwala, Axel Hauschild, et al.
Journal of the American Society for Mass Spectrometry
|
September 29, 2022
Next-Generation Infrared Matrix-Assisted Laser Desorption Electrospray Ionization Source for Mass Spectrometry Imaging and High-Throughput Screening
Kevan T Knizner, Jacob P Guymon, Kenneth P Garrard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial
F Egberts, R Gutzmer, S Ugurel, et al.
Page
of 136